Mesalazine (PENTASA) in Ulcerative Colitis: Correlation of the Information Level With Patient's Compliance in Everyday Practice.
Latest Information Update: 17 Sep 2021
Price :
$35 *
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Acronyms MUKOSA
- Sponsors Ferring Pharmaceuticals
- 14 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 25 Sep 2012 Planned End Date changed from 1 Nov 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov.